New Test Can Help Diagnose Parkinson’s

The DaTscan test is now offered at UCSF and is enabling neurologists to more accurately diagnose Parkinson’s Disease in patients with essential tremor.

Alzheimer’s Patients Benefit from Early PET Scanning, Study Confirms

The interim results from a study sponsored by the Centers for Medicare & Medical Services (CMS) confirm that patients with symptoms of Alzheimer’s disease (AD) who are diagnosed early with PET scans receive medication earlier and, thus, have better clinical outcomes.

Amyloid Imaging: A “Game Changer” in the Diagnosis of Alzheimer’s Disease

The ability to directly detect amyloid during life (as opposed to during autopsy after death) is a potential “game changer” in establishing the early and accurate diagnosis of Alzheimer’s disease. Learn more from UCSF.

An EPIC Approach to Understanding Multiple Sclerosis

UCSF’s Multiple Sclerosis (MS) Research Group, the Department of Radiology’s Neuroradiology Section, and the Surbeck Laboratory for Advanced Imaging are partnering to advance the state of the art for imaging of multiple sclerosis.

Bringing Imaging to Bear Against Multiple Sclerosis

Neuroradiology plays a vital role in the evaluation and treatment of Multiple Sclerosis. UCSF neuroradiologists work closely with the neurologists in the UCSF Multiple Sclerosis Center to achieve the best possible care for patients affected by the disease.

Image Guidance for Minimally Invasive Brain Surgery

Here at UCSF, we are currently working on intra-operative image guidance for the next generation of surgical therapies.

In Defense of Stents

A recent study examined “Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis,” and raised questions about the value of stents for the treatment of strokes.

Brain Tumor Imaging at UCSF: On the Cutting- Edge

UCSF neuroradiologists have pioneered the use of MRI to better evaluate not only physical appearance, but functional and biological characteristics of a variety of brain tumors.

Amyloid Imaging at UCSF

The FDA recently approved Amyvid for use in amyloid imaging in patients being evaluated for Alzheimer’s disease and other causes of cognitive decline. Learn how amyloid imaging works.

New MRI Technique May Predict Progress of Alzheimer

A recent study reported on a new technique that may be able to predict the physical path of Alzheimer’s disease and other degenerative brain diseases.